Turnstone Biologics Corp. (TSBX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 11.45M |
| Enterprise Value | -16.29M |
| P/E Ratio | -0.47 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.56 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.47 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.82 |
| Return On Equity | -1 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.84M |
| EBITDA | -68.97M |
| Net Income | -70.84M |
| Diluted EPS | -3.07 |
| Total Cash | 16.69M |
| Total Cash/Share | 0.72 |
| Total Debt | 411,000 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 3.33 |
| Book Value Per Share | 0.64 |
| 52-Week Change | -46.69 |
| 52-Week High | 2.26 |
| 52-Week Low | 0.29 |
| Moving Average 50 Days | 0.36 |
| Moving Average 200 Days | 0.41 |
| Average Volume | 404,925 |
| Shares Outstanding | 23.14M |
| % Held by Institutions | 36.45 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |